Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia

Approximately half of genetic disease-associated mutations cause aberrant splicing. However, a widely applicable therapeutic strategy to splicing diseases is yet to be developed. Here, we analyze the mechanism whereby IKBKAP-familial dysautonomia (FD) exon 20 inclusion is specifically promoted by a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ajiro, Masahiko, Awaya, Tomonari, Kim, Young Jin, Iida, Kei, Denawa, Masatsugu, Tanaka, Nobuo, Kurosawa, Ryo, Matsushima, Shingo, Shibata, Saiko, Sakamoto, Tetsunori, Studer, Lorenz, Krainer, Adrian R., Hagiwara, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302731/
https://www.ncbi.nlm.nih.gov/pubmed/34301951
http://dx.doi.org/10.1038/s41467-021-24705-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302731/
https://www.ncbi.nlm.nih.gov/pubmed/34301951
http://dx.doi.org/10.1038/s41467-021-24705-5

Ejemplares similares